Ghost Tree Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Ghost Tree Capital’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,000	Closed	-$1.61M	–	72
2023 Q1	$1.61M	Buy	15,000 +5,104	+52%	+$587K	0.48%	44
2022 Q4	$1.09M	Buy	+9,896	New	+$642K	0.46%	31

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Ghost Tree Capital's RXDX Position: Q2 2023 in Review

Ghost Tree Capital sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 15,000 shares — an estimated $1.61M sold.

Ghost Tree Capital first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $1.61M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Ghost Tree Capital reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ghost Tree Capital sold 15,000 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.61M.
Ghost Tree Capital first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Ghost Tree Capital's Prometheus Biosciences, Inc. Common Stock position peaked at $1.61M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Ghost Tree Capital's 13F filing for Q2 2023, filed 14 Aug 2023.